Cell-permeable peptides (CPPs) promote the transduction of nonpermissive cells by recombinant adenovirus (rAd) to improve the therapeutic efficacy of rAd. In this study, branched oligomerization of CPPs significantly enhanced the transduction of human mesenchymal stem cells (MSCs) by rAd in a CPP type-independent manner. In particular, tetrameric CPPs increased transduction efficiency at 3000-5000-fold lower concentrations than did monomeric CPPs. Although branched oligomerization of CPPs also increases cytotoxicity, optimal concentrations of tetrameric CPPs required for maximum transduction are at least 300-1000-fold lower than those causing 50% cytotoxicity. Furthermore, although only B60% of MSCs were maximally transduced at 500 mM of monomeric CPPs, 495% of MSCs were transduced with 0.1 mM of tetrameric CPPs. Tetrameric CPPs also significantly increased the formation and net surface charge of CPP/rAd complexes, as well as the binding of rAd to cell membranes at a greater degree than did monomeric CPPs, followed by rapid internalization into MSCs. In a critical-size calvarial defect model, the inclusion of tetrameric CPPs in ex vivo transduction of rAd expressing bone morphogenetic protein 2 into MSCs promoted highly mineralized bone formation. In addition, MSCs that were transduced with rAd expressing brain-derived neurotrophic factor in the presence of tetrameric CPPs improved functional recovery in a spinal cord injury model. These results demonstrated the potential for tetrameric CPPs to provide an innovative tool for MSC-based gene therapy and for in vitro gene delivery to MSCs.
Introduction
Mesenchymal stem cells (MSCs) have the capacity to differentiate into cells of mesodermal lineage, including adipocytes, chondrocytes, osteocytes and myocytes. 1 This differentiation capacity makes MSCs an attractive treatment for tissue regeneration and engineering. Recently, MSCs have also been shown to have hypoimmunogenic properties due to the absence, or low expression, of major histocompatibility class II and costimulatory molecules. 2 In addition, MSCs have tropism to inflammatory sites, including damaged tissues and tumors. 3, 4 In xenograft experiments using human MSCs, an immunosuppressive agent, such as cyclosporine A, was not necessarily based on the secretion of soluble mediators, such as transforming growth factor-b, interleukin-10 and indoleamine 2,3-dioxygenase, from MSCs that downregulated immune responses associated with the rejection of a xenograft. 5, 6 However, MSCs by themselves have exhibited the limited efficacy in terms of tissue regeneration and specific differentiation to the desired cell types. 7, 8 Therefore, genetic engineering has been proposed as a method to enhance the efficacy of MSC-based therapies.
At present, both nonviral and viral vectors are available for gene delivery strategies. In particular, adenovirus (Ad) has a broad cellular tropism, can produce high levels of transgene expression, is associated with a low risk of insertional mutation, is easy to produce viral stocks with high titers and is able to infect both dividing and nondividing cells. 9 Although replication-deficient recombinant Ads (rAds) lacking the E1 gene have been used for in vivo therapeutic gene delivery, Ad particles directly cause an immediate inflammatory response and acute tissue injury. 10 In addition, locally delivered rAds may disseminate from local lesion to normal tissues, causing systemic toxicity. 11 A few cell types, including MSCs, hematopoietic stem cells and T lymphocytes, are inefficiently transduced with rAd serotype 5 because of the low expression of coxsackievirus and adenovirus receptor (CAR) on these cells. To improve transduction efficiency for these cell types, many approaches have been tested. For example, foreign peptides, such as RGD 12 or poly-lysine, 13 have been inserted into the HI loop or the C terminus of the fiber knob of the Ad vector to target binding of rAd to the cell surface using av integrins or heparin sulfates, respectively. Second, the Ad5 fiber protein has been replaced with Ad35 to infect cells by CD46.
14 Alternatively, cell-permeable peptides (CPPs), such as Tat 48À60 and HP4, although at relatively high concentrations, have been mixed with rAd to increase the transduction efficiency of rAd into various cell types. 15, 16 CPPs are small, poly-basic peptides that have been shown to transverse the plasma membrane of several mammalian cell types, and thus have been used to deliver various bioactive substrates, including proteins, antisense oligonucleotides, liposomes, plasmid DNAs and small interfering RNAs into cells. Recently, multivalent CPPs such as tetrameric decaarginine, decalysine, Tat peptides and zinc(II)-coordinated oligotyrosine have been reported to show improved efficiency in internalization and intracellular delivery of peptide and DNA. [17] [18] [19] In this study, we show, for the first time, that simple oligomerization of CPPs dramatically increased CPPmediated rAd transduction efficiency into MSCs in a CPP-independent manner. This high transduction effect by using tetrameric CPP was shown to be due to simultaneous binding of tetrameric CPPs efficiently to both the cell membrane and rAd compared with monomeric CPPs. Our findings may make it possible for rAd delivery into MSCs to be convenient and cost effective. In addition, our results provide a novel and easy approach for the treatment of hard-to-cure diseases, such as spinal cord injury (SCI) and large segmental bone defects.
Results
Branched oligomeric CPPs significantly enhanced the transduction efficiency of rAd into human MSCs compared with monomeric CPPs
Using four different CPPs, namely Tat,  20 Hph-1,  21 Antp   22 and HP4, 16 a series of branched CPPs were synthesized to include 2, 4, or 8 CPP moieties by conjugating the C termini of the peptides to lysine linkers. Maximum transduction efficiency and minimal cytotoxicity for these synthesized CPPs were evaluated in human bone marrow-derived MSCs (BM-MSCs) and umbilical cord blood-derived MSCs (UCB-MSCs), which do not express CAR ( Figure 1a ). Serial concentrations of CPPs (0.001-500 mM) were included during transduction of cells by rAd expressing enhanced green fluorescent protein (rAd/EGFP) at 100 multiplicity of infection (MOI). In the absence of CPPs, transduction efficiencies of B5 and 8% were observed at 100 MOI rAd in BM-MSCs and UCB-MSCs, respectively. The inclusion of monomeric CPPs at the highest concentration (500 mM) increased rAd transduction to 34-64%, depending on the type of CPP and human MSCs used ( Table 1 ). All of the branched CPPs tested produced significant enhancement in rAd transduction at much lower concentrations than did monomeric CPPs, indicating that the oligomeric effect of CPPs is independent of the CPP type used. In particular, inclusion of tetrameric CPPs at concentrations 3000-5000-fold lower (0.03-0.1 mM) than that of monomeric CPPs, resulted in 495% of cells being transduced. Cellular cytotoxicity of CPPs seemed to be proportional to the degree of oligomerization of Tat or Hph-1, presumably due to the increased net positive charge, and tetrameric and octameric CPPs caused 50% cytotoxicity at concentrations of 30 and 3 mM, respectively. However, there was no significant difference in overall rAd transduction efficiency between tetrameric and octameric CPPs. Considering both safety concerns and transduction efficiency, tetrameric CPPs appeared to be the most effective form in rAd delivery into MSCs.
As shown in Figures 1b and c, MSCs treated with 0.01 and 0.1 mM of tetrameric CPPs resulted in a higher level of EGFP expression than those treated with 100 mM monomeric CPPs. Furthermore, rAd/EGFP transduction efficiency was enhanced as 4Tat concentrations were increased from 0.01 to 0.3 mM. When the effect of viral titer on rAd transduction efficiency was investigated, a significant increase in the number of EGFP-positive cells was observed between 2 and 100 MOI of rAd/EGFP in the presence of 0.1 mM 4Tat (Figure 1d ). For example, treatment with monomeric Tat (100 mM) and 300 MOI of rAd/EGFP resulted in the transduction of B30% of cells. However, when a 1000-fold lower concentration of 4Tat (0.1 mM) was mixed with a 10-fold lower MOI of rAd/EGFP, a slightly higher percentage (B50%) of EGFP-positive cells was detected. These results indicate that rAd transduction was more efficient when a lower rAd was used in combination with tetrameric CPPs. Both 4Hph-1-and 4HP4-treated UCB-MSCs showed B1.5-fold higher mean fluorescence intensity than did 4Tat-and 4Antp-treated cells, but all of them exhibited similar transduction efficiency in percentage (B95% at 0.1 mM, Figures 1e and f). As a negative control, branched oligomerization of irrelevant peptide (LCMV GP 61À80 ) exhibited little effect on rAd transduction efficiency (6.4%), suggesting dependency on the amino-acid composition of monomeric peptide. In all cases, the intrinsic properties of the human MSCs tested, including morphology, proliferative capacity and phenotype, were not significantly altered by treatment with tetrameric CPPs (Supplementary Figures 1a-c) .
Tetrameric Tat enhanced 4Tat/rAd complex formation, binding of the complex to target cell membranes and rAd internalization When the hydrodynamic diameter and zeta-potential of CPP/rAd complexes were assessed by dynamic lighter Branched oligomeric CPP-mediated rAd delivery S-H Park et al scattering, the binding of Tat and 4Tat did not alter the size of the CPP/rAd complex, indicating that the mixture of CPPs and rAds is colloidally stable and does not cause aggregation ( Figure 2a ). As expected, Tat (100 mM) made a change in the overall surface charge of the negatively charged rAd capsid (À11.2 to +9.4 mV, Figure 2b ). Interestingly, 4Tat/rAd complexes (0.1 mM) exhibited much higher surface charge (+20.4 mV) than did monomeric Tat/rAd complexes, which might be caused by an excess positive charge of 4Tat per surface area and by higher binding affinity of 4Tat with rAd capsids than that of monomeric Tat.
To systematically investigate how 4Tat substantially increases transduction efficiency of rAd compared with monomeric Tat, CPPs were labeled with fluorescein isothiocyanate (FITC) and rAd was labeled with either Alexa Fluor 555 or Alexa Fluor 647. The effect of dye labeling on the transduction efficiency and transgene expression was negligible ( Supplementary Figures 2a  and b) . The binding capacity of Tat CPPs for rAd was assessed by adding labeled rAd to glass coated with monomeric Tat or 4Tat, with monomeric Tat applied at a fourfold higher concentration than 4Tat. As shown in Figure 2c , 4Tat (1 mM) was associated with a B10-fold higher fluorescence intensity ratio of rAd to Tat CPPs than monomeric Tat (4 mM). As the fluorescence intensity ratio represents the amount of rAd binding per CPP molecule, this result indicates that the binding capacity of 4Tat is much higher than that of monomeric Tat.
To assess the effect of Tat CPPs on the binding of rAd to the cell membrane, BM-MSCs in suspension were treated with labeled rAd with and without FITC-labeled Tat CPPs. Binding studies were performed at 4 1C in sodium azide-containing buffer to block endocytosis. Monomeric Tat bound 47.9% of BM-MSCs, yet it exhibited only a marginal increase in rAd binding to Branched oligomeric CPP-mediated rAd delivery S-H Park et al the cell membrane compared with rAd alone (1.1 versus 0.8% respectively, Figure 2d ). In contrast, 4Tat bound 94.8% of BM-MSCs, with 53.5% of cells bound by both 4Tat and rAd. Taken together, these results indicate that 4Tat significantly enhances the binding of rAd to the cell membrane (54.3%) compared with monomeric Tat (1.1%). The kinetics of rAd entry into MSCs was also examined and rAd internalization was not detectable 120 min after treatment with and without 4 mM monomeric Tat (Figure 2e ). When a large excess of monomeric Tat (100 mM) was provided, rAd internalization was detected at 60 min. In contrast, treatment with a 100-fold lower molar concentration of 4Tat (1 mM) produced a detectable level of rAd internalization at 1 min, and 4-8-fold higher rAd internalization over time. When cointernalization of rAd with Tat CPPs was evaluated 120 min after treatment, 4 mM monomeric Tat had a minimal effect on the cointernalization of CPP and rAd ( Figure 2f ). In the presence of 100 mM of monomeric Tat, only 4.2% of MSCs cointernalized both CPP and rAd. In contrast, a 100-fold lower concentration of 4Tat (1 mM) resulted in the cointernalization of both CPP and rAd in 66% of MSCs. Taken together, these results indicate that tetrameric oligomerization of Tat resulted in significantly facilitating rapid internalization of rAd into MSCs. To further determine whether 4Tat and rAd are internalized as a complex, confocal microscopy was used to detect the internalization process at 5, 30 and 120 min after treatment with CPP and rAd. In the presence of monomeric Tat, neither rAd nor CPPs were detectable before 30 min (Figure 2g ). The fluorescent signal did increase by 120 min; however, the fluorescence of rAd did not overlap with that of monomeric Tat (Supplementary Figure 3a) . In contrast, internalization of rAd and 4Tat were readily observed 5 min after treatment, and both signals predominantly colocalized in both the nuclei and the cytosol after 30 min (Supplementary Figure 3b ). These results suggest that a complex forms between 4Tat and rAd within the target cell. As it has been shown that rAd is disassembled in the endosome and the cytosol before importation of viral DNA into the nucleus, and that Tat CPP can enter the nucleus, 20 the nuclear bright-red fluorescence observed may represent uncoated capsid proteins rather than the virus itself.
BM-MSCs transduced ex vivo with rAd/BMP2 plus tetrameric Tat exhibited highly mineralized bone formation in a calvarial bone defect model Bone morphogenetic protein 2 (BMP2) exerts a potent therapeutic effect by inducing osteogenic differentiation of MSCs leading to bone regeneration.
23 BMP2-expressing rAd (rAd/BMP2) was constructed and applied to a calvarial defect model in rats with transduction of BM-MSCs performed in the presence or absence of monomeric Tat or 4Tat. BMP2 expression was detected at 50 and 100 MOI of rAd/BMP2 with and without 0.4 mM monomeric Tat (Figure 3a) . In the presence of 0.1 mM 4Tat, a detectable level of BMP2 was observed at a much lower titer (1 MOI of rAd/BMP2), and at MOIs between 1 and 50, a 4130-fold increase in BMP2 expression was detected. Only a slight increase in BMP2 expression was further achieved with 100-500 MOI rAd/BMP2. The level of BMP2 expression was also found to be dose dependent, with a minimal level of BMP2 detected at 0.01 mM 4Tat, and significantly higher levels of BMP2 detected from 0.03 to 0.3 mM 4Tat (Figure 3b ). Quantitation of BMP2 levels in the presence of 0.1 mM 4Tat detected B40 ng BMP2 that was produced by 5 Â 10 5 BM-MSCs over 24 h, which was a level at least 30-fold higher than that obtained in the presence of a 1000-fold higher molar concentration of monomeric Tat (100 mM).
In vivo experiments using 50 MOI of rAd/BMP2 with or without 0.1 mM 4Tat or 0.4 mM monomeric Tat were performed to investigate the capacity for MSCs expressing BMP2 to stimulate bone regeneration in a rat calvarial defect model. Treatment with Matrigel alone or Matrigel carrying BM-MSCs/rAd-BMP2 ( ± 0.4 mM Tat), showed no significant effect on calvarial regeneration (Figures 3c and d) . In contrast, implantation of Matrigel carrying BM-MSCs/rAd-BMP2 with 0.1 mM 4Tat resulted in extensive new bone formation that bridged the calvarial defect and significantly increased bone mineral content (Po0.01). It is noteworthy that highly mineralized bone was regenerated within 4 weeks of administering a single injection of rAd-transduced BM-MSCs without inclusion of osteoinductive scaffolds. When hematoxylin and eosin and Masson's Trichrome staining were performed, periosteum and fibrous connective tissue were primarily detected in the calvarial defects of rats treated with Matrigel alone, or Matrigel with BM-MSCs/rAd-BMP2 (±0.4 mM Tat) (Figures 3e  and f) . In contrast, a relatively thick, compact and Values are the averages±s.e.m. of three independent experiments, with data outside and inside the parentheses representing human BM-MSCs and UCB-MSCs, respectively. The maximum concentration of CPPs used was 500 mM; 4500, 50% cytotoxicity was not detected below a CPP concentration of 500 mM.
Branched oligomeric CPP-mediated rAd delivery S-H Park et al well-organized cortical bone was formed in rats treated with Matrigel/BM-MSCs/rAd-BMP2 in the presence of 0.1 mM 4Tat.
BM-MSCs transduced ex vivo with rAd/BDNF plus tetrameric Tat exhibited improved functional recovery in a SCI model
Brain-derived neurotrophic factor (BDNF) promotes the survival and differentiation of neuronal tissue; 24 therefore, rAd expressing BDNF (rAd/BDNF) was constructed and applied to a SCI model. To investigate the effect of 4Tat, BM-MSCs were transduced with rAd/BDNF at an MOI ranging from 0.1 to 100 with or without 4Tat or monomeric Tat. Higher expression levels of BDNF were observed as the MOI of rAd/BDNF was increased (Figure 4a) , and the expression of BDNF was up to 300-fold higher in the presence of 4Tat (0.1 mM) than with monomeric Tat (0.4 mM). BDNF expression in vivo was detected 1 week after transplantation of transduced BM-MSCs into a rat SCI model. The expression of BDNF at the injury site was found to be consistently higher in the 4Tat-treated group than in the other groups (Po0.05), with the expression of BDNF returning to basal levels after 4 weeks (Figure 4b ). Phosphate-buffered saline (PBS)-treated rats that served as a negative control exhibited 9.3 points of a BassoBeattie-Bresnahan (BBB) score and sustained functional defects in their behavior 6 weeks after transplantation (Figure 4c ). Treatment of SCI rats with BM-MSCs/rAd-BDNF resulted in a higher BBB score of 10.2 compared with the control group, which is consistent with previous reports. 25, 26 The presence of monomeric Tat during transduction marginally increased the BBB score of SCI rats 4-6 weeks after transplantation (10.8 points 6 weeks after treatment); however, the BBB score was significantly higher in 4Tat-treated SCI rats early as 3 weeks after transplantation. This relatively high BBB score was maintained through the end of the study (13.1 points 6 weeks after treatment). When spinal cord cavity volume and BBB score were compared 6 weeks after transplantation, the BBB score appeared to be proportional to the reduction in cavity volume detected in the spinal cord (Figure 4d ). In particular, the 4Tat-treated group exhibited Branched oligomeric CPP-mediated rAd delivery S-H Park et al a markedly reduced volume of the spinal cord cavity compared with the monomeric Tat-treated group (Po0.05). Luxol fast blue staining further detected improved myelin profiles for 4Tat-treated rats versus monomeric Tat-treated and control SCI rats (Figure 4e ).
Discussion
In this study, we provide a novel and promising method using a branched oligomerization of CPPs, which resulted in highly improved CAR-independent adenoviral transduction of MSCs compared with monomeric CPPs in a CPP type-independent manner. Hence, our findings significantly improved the previous reports that monomeric CPPs such as Tat 48À60 , Antp and HP4 enhanced rAd-mediated gene delivery into nonpermissive cells. 15, 16 In particular, higher transduction efficiencies were achieved using concentrations of branched tetramers of CPPs at 3000-5000-fold less than that of monomeric CPPs. It is notable that branched oligomerization could increase not only rAd transduction efficacy but also cytotoxicity of CPPs, but optimal concentrations required for maximum transduction (0.03-0.1 mM) are 300-1000-fold lower than concentrations causing 50% toxicity (10-30 mM), suggesting that tetrameric CPPs could be used for safe ex vivo transduction of rAd into MSCs. It would be predicted that oligomeric CPPs could have higher avidities for rAd than monomeric CPPs, presumably due to the multiple interactions Branched oligomeric CPP-mediated rAd delivery S-H Park et al with rAd. In addition, they may bind both rAd and the cell membrane at the same time more efficiently than monomeric CPPs. Thus, the results observed in this study may be attributed to not only increased oligomeric CPP/rAd complex formation but also simultaneous binding of these complexes to both rAd and the cell membrane.
It was reported that most of CPPs used so far contain a number of basic amino acids such as arginine and lysine, which are key residues for CPP function. 27 A lesser degree of internalization was observed for the peptides containing the smaller number of arginine residues in the sequences, implying that the CPP function is dependent on the amino-acid composition. 28 In addition, the aminoacid sequence (the order of amino acid) of a peptide is not a critical factor affecting the CPP function, because Antp 58À43 , which has a reverse amino-acid sequence with same amino-acid compositions as Antp 43À58 CPP, still has CPP function. 22 Taken together, the effects of branched oligomerization seem to be dependent on amino-acid Branched oligomeric CPP-mediated rAd delivery S-H Park et al composition with CPP function, but not on amino-acid sequence. Several strategies to improve the efficiency of rAd transduction into nonpermissive cells have been tested. First, cationic polymers and lipids, which form complexes with adenoviral particles, have been used to facilitate in vitro transduction of a range of cell types by rAd. 29, 30 In fact, although protamine sulfate, which is one of the well-known cationic polymer, increased rAd delivery into several cell lines and primary cells, lower transduction efficiency (B70%) was shown in MSCs (Supplementary Table 1 ). On the other hand, high molecular weight poly-L-lysine, polybrene, DEAEDextran and lipofectamine showed similar transduction efficiency (490%) of MSCs by rAd compared with tetrameric CPPs. However, one big difference between tetrameric CPPs and cationic polymers or lipids is cytotoxicity, because the cytotoxicity of cationic polymers and lipids is at least 10-300-fold higher than that of tetrameric CPPs. Second, a CAR-CPP fusion protein that binds to rAd and the cell membrane simultaneously appeared to mediate rAd transduction of CAR-negative cells with high efficiency. 31 Alternatively, CPP domains have been directly fused to the fiber of rAd and were shown to efficiently deliver rAd to CAR-negative cells. 32, 33 In comparison with these previous studies, our results show that branched oligomeric CPPs, which are inexpensive and easily synthesized, are broadly applicable to any preexisting rAd to achieve 495% transduction of human MSCs. Thus, our findings represent a simple, cost effective and efficient tool for ex vivo gene delivery into stem cells, and make it possible for stem cell-based gene therapy of hard-to-cure diseases, such as SCI, stroke and cancer to be conveniently performed.
Materials and methods

Peptides
All peptides such as Tat (GRKKRRQRRRPPQ), 2Tat, 4Tat, 8Tat, Tat-FITC, 4Tat-FITC, Hph-1 (YARVRRRGPRR), 2Hph-1, 4Hph-1, 8Hph-1, Antp (RQIKIWFQNRRMKWKK), 4Antp, HP4 (RRRRPRRRTTRRRR), 4HP4, LCMV GP 61À80 (GLNGPDIYKGVYQFKSVEFD) and 4GP 61À80 were synthesized by Peptron Co. (Daejeon, Korea). For synthesis of branched peptides, the 2-, 4-and 8-branch multiple antigen peptide resins were used.
Replication-defective adenoviral vectors
Recombinant replication-defective adenoviruses (rAd) expressing EGFP, human BMP2 and BDNF were generated using the AdEasy Vector System (QBioGene, Carlsbad, CA, USA) as described previously. 34 Titers of rAd were determined using the tissue culture infectious dose 50 method according to the supplier's protocol (QBioGene). All concentrations of rAd indicated in the experimental descriptions are based on an MOI of plaque-forming units per cell.
In vitro adenovirus transduction
Human UCB-MSCs were kindly provided by Medipost Co. (Seoul, Korea), and BM-MSCs were purchased from FCB-Pharmicell Co. (Seongnam, Korea). UCB-MSCs and BM-MSCs were cultured in a-minimal essential medium and Dulbecco's modified Eagle's medium with low glucose medium supplemented with 10% fetal bovine serum, respectively. rAd/EGFP, rAd/BMP2 or rAd/ BDNF at various MOIs (0.1B500 MOI) was diluted in serum-free medium to achieve a 2 Â virus dilution. CPPs (0.001B500 mM) were similarly diluted in serum-free medium to yield 2 Â dilution. Virus and CPP mixtures were combined at a 1:1 ratio and allowed to incubate for 30 min at room temperature. Cells (3 Â 10 4 ) were treated with the CPP/rAd mixture for 2 h (for EGFP) or 30 min (for BMP2 and BDNF) in 48-well plates, and then the medium was changed to fresh serum-containing medium. After additional 48-h incubation, EGFP expression was analyzed using FACSCalibur (BD Biosciences, San Diego, CA, USA). Density plots of live cell populations (5000 cells) were gated on EGFP-positive cells based on untreated controls, which showed B0.1% EGFP-positive cells. The secretion levels of BMP2 and BDNF were analyzed by enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN, USA) using culture supernatant after 24-h incubation.
CAR expression
Human UCB-MSCs and BM-MSCs (1 Â 10 6 ) were stained with mouse anti-human CAR IgG 1 Ab (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 30 min. After washing, FITC-conjugated rat anti-mouse IgG 1 Ab (eBioscience, San Diego, CA, USA) was added and incubated for 30 min. Cells were fixed with in PBS containing 1% formaldehyde and analyzed by FACSCalibur. FITC-conjugated IgG 1 Ab (BD Biosciences) was used as an isotype control.
Cytotoxicity test
Human UCB-MSCs and BM-MSCs (1 Â 10 4 ) were treated with increasing concentrations (0.001B500 mM) of CPPs. After 24-h incubation, 10 ml MTT (5 mg ml
À1
; Sigma, St Louis, MO, USA) was added. After 4-h incubation, the produced formazan was dissolved in acid-isopropanol solution (0.04 N HCl/isopropanol). The absorbance at 570 nm was then determined using a microplate reader. Cell viability was expressed as the ratio of the absorbance at 570 nm of CPP-treated cells to the untreated.
Particle size and zeta-potential
For determining the diameter and zeta-potential of CPP/rAd complexes, 2 Â 10 9 viral particles (VPs) of rAd/BDNF was mixed and preincubated with 100 mM of Tat or 0.1 mM of 4Tat in distilled water for 30 min. The size and zeta-potential measurement of each sample were taken in 1 ml total volume using the Zetasizer Nano ZS (Malvern Instruments, Malvern, UK).
Assessment of membrane-binding capability and internalization of rAd and CPPs rAd was labeled with Alexa Fluor 647 (far red, for flow cytometry) or 555 (red, for microscopy) by mixing carboxylic acid, succinimidyl ester form of dyes (Invitrogen, Carlsbad, CA, USA), which specifically reacts with primary amine, with 2 Â 10 12 VPs per ml of rAd/BDNF at the molar ratio of 1:5000 or 1:10 000, respectively, and then dialyzed in PBS using 10-K MWCO Slide-A-Lyzer Mini Dialysis Units (Pierce, Rockford, IL, USA). Glass bottoms of 8-well chamber slides (Nunc, Rochester, NY, USA) were coated with either 4 mM of Tat-FITC or 1 mM of Branched oligomeric CPP-mediated rAd delivery S-H Park et al 4Tat-FITC overnight, and then washed three times by PBS, followed by incubation with rAd labeled with Alexa Fluor 555 (7.2 Â 10 9 VPs) for 1 h. Fluorescent images were acquired using the Zeiss Observer (Zeiss, Jena, Germany). Normalized binding of rAd to Tat per molecule was calculated by taking the ratio of Alexa Flour 555 signal to the FITC signal using Metamorph (Molecular Devices, Sunnyvale, CA, USA).
For surface-binding assay, human BM-MSCs (1 Â 10 5 ) were trypsinized, preincubated with 30 mM sodium azide for 10 min and then treated with the mixture of Alexa Fluor 647-labeled rAd (100 MOI) and CPP-FITCs which were preincubated for 30 min in the presence of 30 mM sodium azide at 4 1C suspended condition. After incubation for 30 min, the level of membrane-bound rAd and CPPs was analyzed using FACSCalibur.
For internalization assay, Tat-FITC or 4Tat-FITC was mixed with rAd labeled with Alexa Fluor 647 (100 MOI), preincubated for 30 min and then treated to BM-MSCs (3 Â 10 4 ) preplated in 48-well plates for 1-120 min. For fluorescence-activated cell sorting analysis, all the cells were harvested by trypsinization, which removes surface-bound molecules and viral particles. 35 Thus, most of the signals obtained after trypsinization will be derived from internalized CPPs and/or rAd.
For confocal imaging, 300 MOI of rAd labeled with Alexa Fluor 555 were preincubated with Tat-FITC or 4Tat-FITC for 30 min and treated to BM-MSCs (2 Â 10 4 ) for 5, 30 and 120 min in 8-well chamber slides (Nunc). Cells were then fixed with 2% paraformaldehyde, and confocal microscopy was performed to examine internalization and localization of CPPs and rAd. Z stacks of differential interference contrast (DIC), green fluorescence and red fluorescence images were acquired every 1 mm with 40 Â objective lens (Olympus FV1000, Olympus, Tokyo, Japan). Acquired images were processed using Metamorph.
Calvarial bone defect model
Calvarial bone defects (8 mm) of 6-week-old male Sprague-Dawley rats were induced as described previously. 36 The defects were transplanted with PBS or 5 Â 10 5 BM-MSCs/rAd-BMP2 suspended in Matrigel matrix (BD Biosciences). BM-MSCs/rAd-BMP2 were generated by transduction of BM-MSCs with rAd/ BMP2 (50 MOI) in the presence and absence of 0.4 mM of monomeric Tat or 0.1 mM of 4Tat. The rats (n ¼ 4) were killed at 4 weeks after transplantation and the operative field at the calvaria was removed from the skull, fixed with 4% paraformaldehyde for 24 h. Three-dimensional calvarial bone images were reconstructed using microcomputed tomography (SMX-90CT inspexio, Shimadzu, Kyoto, Japan) and VG studio Max (Volume Graphics, Heidelberg, Germany) and the regenerated bone mineral contents in original defect were calculated with TRI/3D-VIE (RATOC System Engineering, Tokyo, Japan). Calvarias were decalcified by incubating in 7% nitric acid solution, dehydrated and embedded in paraffin. For histochemical analysis, paraffin sections were cut in the midline of calvarial defect and stained with hematoxylin and eosin and Masson's Trichrome using standard procedures. This experiment was reviewed and approved by the Institutional Animal Care and Use Committee of Seoul National University and was conducted according to the committee's guidelines.
SCI model
SCI of 6-week-old male Sprague-Dawley rats was induced as described previously. 37 Briefly, the impact rod of the New York University weight-drop device was centered above T9 and dropped from a height of 25 mm to induce a moderate-to-severe contusion injury. A total of 3 Â 10 5 BM-MSCs were transduced by rAd/BDNF (50 MOI) with or without CPPs (0.4 mM of monomeric Tat or 0.1 mM of 4Tat) and then transplanted into the injury site of the spinal cord at 1 week after injury (3 Â 10 5 cells). To investigate the local BDNF expression level in vivo, spinal cords (n ¼ 3) were harvested at 1 or 4 weeks after transplantation and homogenized for enzyme-linked immunosorbent assay. The motor function restoration after SCI was observed by open field BBB locomotor ration scale (n ¼ 7). 38 To measure the cavity volume, longitudinal paraffin sections were stained with hematoxylin and eosin 6 weeks after transplantation, and the area of cavities was measured from 8 consecutive sections at an interval of 50-mm by an image analysis system (Metamorph). The volume of the cavity was then calculated by multiplying the average area by depth of the spinal cord as previously reported. 39 The other sections were stained with luxol fast blue for myelin. This experiment was reviewed and approved by the Institutional Animal Care and Use Committee of the Catholic University of Korea and was conducted according to that committee's guidelines.
Statistical analysis
To measure the statistical difference between groups, Student's t-test was used. For all statistical tests, P-values o0.05 were considered statistically significant.
